A50 — Washington D.C., District of Columbia

A50 is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

A50 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Myasthaenia Gravis.

Sponsors: Cartesian Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for A50?

A50 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has A50 conducted?

A50 has 1 clinical trials on record, with 1 currently active. Their work covers Myasthaenia Gravis.

Is A50 accredited by Crixeo Health?

A50 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about A50?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.